1. Best Pharmaceuticals for Children. Food and Drug Administration and the National Institutes of Health.
https://bpca.nichd.nih.gov/Pages/default.aspx
. Accessed on 2/11/2017.
2. US Food and Drug Administration. Intra-agency agreement between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the U.S. Food and Drug Administration (FDA) oral formulations platform—report 1. https://bpca.nichd.nih.gov/collaborativeefforts/initiatives/documents/formulations_platform_report1.pdf . Accessed on 2/11/2017.
3. US Food and Drug Administration. Inter-agency agreement between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the U.S. Food and Drug Administration (FDA) final report. https://bpca.nichd.nih.gov/collaborativeefforts/initiatives/Documents/Formulations_Platform_Report2.pdf . Accessed on 2/11/2017.
4. Better medicines for children. European Medicines Agency.
www.ema.europa.eu/docs/en_GB/document_library/Other/2009/12/WC500026493.pdf
. Accessed on 2/11/2017.
5. Reflection paper: formulations of choice for the paediatric population. European Medicines Agency.
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003782.pdf. Accessed on 2/11/2017
.